Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 148,232 | 84,772 | 200,481 | 237,170 | 67,019 |
| Marketable Securities | 372,639 | 276,817 | 255,786 | 220,206 | 289,441 |
| Receivables | 30,239 | 33,067 | 28,640 | 34,186 | 18,085 |
| Inventories | 7,183 | 7,608 | 7,259 | 6,286 | 6,593 |
| TOTAL | $565,040 | $410,407 | $497,682 | $505,562 | $406,630 |
| Non-Current Assets | |||||
| PPE Net | 11,697 | 9,418 | 5,696 | 2,930 | 2,617 |
| Intangibles | 152,278 | 154,125 | 155,153 | 156,307 | 157,013 |
| Other Non-Current Assets | 35,030 | 33,489 | 33,689 | 13,895 | 6,803 |
| TOTAL | $199,005 | $197,032 | $194,538 | $173,132 | $166,433 |
| Total Assets | $764,045 | $607,439 | $692,220 | $678,694 | $573,063 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,008 | 12,133 | 9,431 | 10,198 | 9,966 |
| Accrued Expenses | 46,467 | 56,793 | 50,320 | 44,379 | 41,590 |
| Other current liabilities | 23,538 | 23,377 | 15,675 | 15,356 | 16,535 |
| TOTAL | $85,013 | $92,660 | $75,426 | $69,933 | $68,091 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 316,343 | 303,566 | 315,381 | 290,116 | 279,224 |
| TOTAL | $316,343 | $303,566 | $315,381 | $290,116 | $279,224 |
| Total Liabilities | $401,356 | $396,226 | $390,807 | $360,049 | $347,315 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,458 | 60,236 | 51,052 | 50,906 | 43,156 |
| Common Shares | 6 | 5 | 5 | 5 | 4 |
| Retained earnings | -639,742 | -585,875 | -464,253 | -441,704 | -415,636 |
| Other shareholders' equity | -262 | -902 | 354 | 1,399 | -1,500 |
| TOTAL | $362,689 | $211,213 | $301,413 | $318,645 | $225,748 |
| Total Liabilities And Equity | $764,045 | $607,439 | $692,220 | $678,694 | $573,063 |